![](https://entrepreneurs.utoronto.ca/wp-content/uploads/2021/08/Paradox-logo-therapeutics.jpg)
Paradox Immunotherapeutics
We are a pharmaceutical company dedicated to the creation of antibody therapies for the treatment of rare protein misfolding diseases, including those characterized by amyloidosis.¬† Paradox’s scientific team has proven expertise and know-how to selectively target misfolded proteins with monoclonal antibodies with a proven track record of success.